tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

AKTX Stock Latest News

Akari Therapeutics Reports Full-Year 2023 Financial Results and Recent Highlights
Press ReleasesAkari Therapeutics Reports Full-Year 2023 Financial Results and Recent Highlights
23d ago
AKTX
Akari Therapeutics Announces Strategic Merger with Peak Bio
PremiumCompany Announcements
Akari Therapeutics Announces Strategic Merger with Peak Bio
2M ago
8K
AKTX
Akari Therapeutics, Peak Bio announce definitive agreement to merge as equals
PremiumThe Fly
Akari Therapeutics, Peak Bio announce definitive agreement to merge as equals
2M ago
AKTX
PKBO
Akari Therapeutics and Peak Bio Announce Definitive Agreement to Merge as Equals Creating an Expanded Pipeline That Features a Novel Antibody Drug Conjugate (ADC) Toolkit
PremiumPress Releases
Akari Therapeutics and Peak Bio Announce Definitive Agreement to Merge as Equals Creating an Expanded Pipeline That Features a Novel Antibody Drug Conjugate (ADC) Toolkit
2M ago
AKTX
Akari Therapeutics issues 947,868 ADSs at $2.11 in private placement
PremiumThe Fly
Akari Therapeutics issues 947,868 ADSs at $2.11 in private placement
4M ago
AKTX
Akari Therapeutics Announces Existing Investors Support the Company Through a $2 Million Private Placement Financing
PremiumPress ReleasesAkari Therapeutics Announces Existing Investors Support the Company Through a $2 Million Private Placement Financing
4M ago
AKTX
Akari Therapeutics to Present at Biotech Showcase 2024
PremiumPress Releases
Akari Therapeutics to Present at Biotech Showcase 2024
4M ago
AKTX
Akari Therapeutics appoints Samir Patel to board of directors
PremiumThe Fly
Akari Therapeutics appoints Samir Patel to board of directors
5M ago
AKTX
Akari Therapeutics presents poster on progress on PASylated-nomacopan
PremiumThe Fly
Akari Therapeutics presents poster on progress on PASylated-nomacopan
5M ago
AKTX
Akari Therapeutics files to sell 1.285B ordinary shares for holders
PremiumThe Fly
Akari Therapeutics files to sell 1.285B ordinary shares for holders
6M ago
AKTX
Akari Therapeutics Reports First Half 2023 Financial Results and Highlights
PremiumPress Releases
Akari Therapeutics Reports First Half 2023 Financial Results and Highlights
7M ago
AKTX
Akari Therapeutics expects cash to fund operations into 1Q24
PremiumThe Fly
Akari Therapeutics expects cash to fund operations into 1Q24
7M ago
AKTX
Akari Therapeutics reports 1H EPS 0c vs. 0c last year
PremiumThe FlyAkari Therapeutics reports 1H EPS 0c vs. 0c last year
7M ago
AKTX
Akari Therapeutics to Present at Emerging Growth Conference
PremiumPress Releases
Akari Therapeutics to Present at Emerging Growth Conference
7M ago
AKTX
Akari Therapeutics enters definitive purchase agreements with existing investors
PremiumThe Fly
Akari Therapeutics enters definitive purchase agreements with existing investors
7M ago
AKTX
Akari Therapeutics to Host Key Opinion Leader Webinar on Hematopoietic Stem Cell Transplant-Related Thrombotic Microangiopathy (HSCT-TMA) and the Potential of Nomacopan to Address Significant Unmet Needs
PremiumPress Releases
Akari Therapeutics to Host Key Opinion Leader Webinar on Hematopoietic Stem Cell Transplant-Related Thrombotic Microangiopathy (HSCT-TMA) and the Potential of Nomacopan to Address Significant Unmet Needs
7M ago
AKTX
Akari Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement
PremiumPress Releases
Akari Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement
8M ago
AKTX
Akari Therapeutics regains compliance with Nasdaq minimum bid price requirement
PremiumThe Fly
Akari Therapeutics regains compliance with Nasdaq minimum bid price requirement
8M ago
AKTX
Akari Therapeutics Announces Establishment of Boston U.S. Headquarters Office to Support Expanding Operations and Start of Registrational Phase 3 Clinical Trials
PremiumPress Releases
Akari Therapeutics Announces Establishment of Boston U.S. Headquarters Office to Support Expanding Operations and Start of Registrational Phase 3 Clinical Trials
8M ago
AKTX
Akari Therapeutics announces establishment of headquarters in Boston
PremiumThe FlyAkari Therapeutics announces establishment of headquarters in Boston
8M ago
AKTX
Akari Therapeutics, Plc Announces ADS Ratio Change
PremiumPress Releases
Akari Therapeutics, Plc Announces ADS Ratio Change
8M ago
AKTX
Akari Therapeutics announces ADS Ratio change
PremiumThe Fly
Akari Therapeutics announces ADS Ratio change
8M ago
AKTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >